Loading HepaSphere Microspheres with Lyophilized Doxorubicin

Similar documents
English INSTRUCTIONS FOR USE

INSTRUCTIONS FOR USE. English

MEDICATION AND INJECTION ADMINISTRATION EDUCATIONAL BOOKLET FOR OVULATION INDUCTION

How to Give a Subcutaneous (SC) Injection to Your Child

Procedure 30 Collecting A Blood Specimen Using The Vacuum-Tube System. Procedure 31 Collecting A Blood Specimen Using A Needle And Syringe

Lenis Needle-free Safety Syringe Device User Manual

Migraine Attack Abortive Treatment Medication Overuse Protocol Treatment Refractory Cluster Headache Treatment

Instructions for Use BYDUREON (by-dur-ee-on) Single-Dose Tray (exenatide extended-release) for injectable suspension

A NON-SURGICAL SKIN REJUVENATION TREATMENT

Surgical Gown. Tongue Depressor. A disposable gown worn by medical staff during surgery. A thin, flat, wooden stick rounded at both ends

TRANSGENDER HEALTH Injection Guide

SOP BIO-002 FOR SHARPS USAGE AND DISPOSAL

Student Performance Guide. Student Performance Guide. Student Performance Guide. Student Performance Guide. LESSON 3-3 Bleeding Time

Revised 1/10. Copyright 2010 St. Jude Children's Research Hospital Page 1 of 5

State of Kuwait Ministry of Health Infection Control Directorate SAFE INJECTION

I.V. INJECTION ARM P50/1 ( ) USER MANUAL

In Activity 12, Evaluating Materials, and Activity 13, Product Life

Instructions For Use:

ATS-SOI-5731 Page: 1 of 5. Approval Block. Prepared by: Signature Date Margaret Crouse 18 JUN Reviewed by: Signature Date

TECHNICAL INFORMATION Adhesive-Side Powder Development Catalog Nos. ASP150, ASP50D, ASP50L, TRA20

Urine Collection Kit. just between us. This kit contains: Before you begin! Access Key label here

DZC Marketing 15, Jalan Radin Anum 2, Bandar Baru Sri Petaling Kuala Lumpur, Malaysia. Tel : Fax :

deep color complex safe lightener complex deep color maintainer balm

Figure A. Figure B To prevent premature activation of the needle safety guard, do not touch the NEEDLE GUARD ACTIVATION CLIPS at any time during use.

Appendix L: Accessing/Deaccessing Implanted Central Venous Access Port

Dangerous Things DIY RFID Implantation Guide Written by Amal Graafstra

The Lab Report. TrueAllele & DNA Mixtures. New Blood Collection Kits. Laboratory Training Day. "Justice through Science" TrueAllele & DNA Mixtures

Hydryalix Advantages. Composition. Hydryalix

SWISS INNOVATION APPLIED TO BEAUTY. Ultimate. Intense volume

Handling and Disposing of Needles

Hints & Tips for Stain Removal

LYMPHOCYTE ISOLATION

LAB 5 Blood Collection

MESO-NEEDLING. A new technique for new indications. Rejuvenation Alopecia

Terumo Neolus. Hypodermic needles. Hospital Systems. Unsurpassed comfort for patient and medical staff

For Pricing and Ordering Please Call

Innovation in Skin Regeneration

ABOUT MD SKIN SOLUTIONS

Instructions for Use. (dulaglutide) injection, for subcutaneous use. 1.5 mg/0.5 ml Single-Dose Pen. once weekly. Unfold and lay flat

Tospearl 145A. Tospearl 120A

When your eyes feel dry, burning or itchy, there s a range of solutions:

PHYSICAL EVIDENCE. Something that shows or proves, or that gives reason for believing; proof or indication (Webster s New World Dictionary;1995) tox

THE NEW 100 % PROFESSIONAL SYSTEM THAT ELEVATES THE QUALITY OF TECHNICAL SERVICES IN YOUR HAIR SALON

Original Date:

Administering ORENCIA (abatacept): Your Step-by-Step Guide

Standard Operating Procedure for Blood Borne Infectious Disease Control Measures at Calvin College

Instructions For Use PRALUENT (PRAHL-u-ent) (alirocumab) Injection, for Subcutaneous Injection Single-Dose Pre-Filled Pen (75 mg/ml)

28 Questions Frequently Asked Questions that everyone should know!

. DEFY LINES. along the sides of your nose and mouth ON YOUR FACE.

B-SERIES CONVERSION INSTRUCTIONS

with exclusive Tri-Grain Fortiplex Where healthy, beautifully radiant skin begins...

Sterilization A Training Module

under Council Medical Devices Directive (93/42/EEC) as updated directive 2007/47/EEC

INJECTING EFFICIENCY FROM SET-UP TO CLEAN-UP.

Congratulations on your purchase of a. airbrush.

FAB MEDIC LTD Product webpage:

WILLOWWOOD ONE TRANSTIBIAL SYSTEM

SITE PROCEDURES BLOOD SPECIMENS

INFECTION PREVENTION AND CONTROL PLAN

Safety Rules for Laboratory

Hyalurosmooth. by Beauty Creations. Natural fine line and wrinkle filler

Comparative Proteomics Kit II: Western Blot Module Quick Guide

Phase Separation Science, Inc.

GAR Labs is a large Skin Care & Hair Care Manufacturer

K²LISS WHY K2LISS? So, K2LISS means THE SOLUTION TO GET SMOOTH HAIR, making it straighter and extremely radiant.

Page 1 of 6 BODY ART FACILITY PLAN CHECK GUIDELINES

Safe Handling and Disposal of Sharps. Reference Guide

Medical device OPKOHealth OCULAR DROPSVIS ACTIV NEO muhl dose 10 mi. Sterile Page: 30 of 34

Laboratory technique and preparations

STELARA INJECTION. What is in this leaflet. Before you use STELARA. What STELARA is used for. Consumer Medicine Information

Do not take Neulasta if you have had a serious allergic reaction to pegfilgrastim (Neulasta ) or to filgrastim (Neupogen ).

GETTING COMFORTABLE WITH TAKING STELARA

2 x 1mL. Manufacturer: ALLERGAN Route de Promery Zone Artisanale de Pré-Mairy PRINGY-FRANCE

PERM HISTORY. The first perm dates back to Louis XIV of France London hairdresser Nessler used borax.

ab Trichrome Stain (Connective Tissue Stain)

An innovation in Filler Technology

A new generation of llers and mesotherapy products. The ne art of aesthetics by CROMA. Dare to be perfect

EXERCISE 8C - Lab Procedures

Your Step-by-Step Guide

Estapor White Microspheres. A critical raw material for the manufacture of IVD and life sciences reagents

Phlebotomy Training. for Clinical Research Coordinators

Manufacturer: ALLERGAN Route de Promery Zone Artisanale de Pré-Mairy PRINGY-FRANCE

The Effects of Oil Spills on Birds: why do feathers float on water but not oil?

Biohazardous Waste. 1. Solid Biohazardous Waste (non-sharps) Storage

NATURAL COSMETICS NATURALI The natural cosmetics product line "WineCosmetics" is almost entirely made of substances of natural origin.

ROBOT PIN TOOL CLEANING AND LIQUID SAMPLE TRANSFER

PRODUCT NUMBER: Nomex JACKET

MEDICAL WASTE MANAGEMENT

V O L I F T. 2 x 1mL. Manufacturer: ALLERGAN Route de Promery Zone Artisanale de Pré-Mairy PRINGY-FRANCE

SHARPS MANAGEMENT AND DISPOSAL OF SHARPS, SYRINGES & CONTAMINATED PRODUCTS

AN INDEPENDENT ASSESSMENT OF INK AGE DETERMINATION BY A PRIVATE EXAMINER Erich J. Speckin

MAINTENANCE GUIDE. Keep your wood floor looking beautiful

Preparing the Gel Box and Pouring the Agarose Gel

There are few side-effects in mesotherapy. In most cases, they are minor and reversible:

TATTOO CATALOGUE 2018

Dräger Oxy 3000/6000 Self Contained Self Rescuer

Company Introduction. Daewoong Pharmaceutical. DNCompany (DNC) Affiliate relationship. Founded in 2001

ab Elastic (Connective Tissue Stain)

Regulated Medical Waste. Be sure to sign in!

Medications and Medication Safety

Transcription:

Loading HepaSphere Microspheres with Lyophilized Doxorubicin 1 A Step-by-Step Reference for Clinicians

in 1 vial Supplies 1 x doxorubicin powder vial 1 HepaSphere Microspheres vial 4 x 20G needles or larger (18G preferred) 2 x 30mL syringes or larger 2 x vials preservative-free 0.9% sodium chloride for injection - DO NOT USE STERILE WATER 1 x syringe cap Prepare in Biohazard Hood Lift the cap from the HepaSphere Microspheres vial to the vertical position taking care NOT to remove the cap or the metal retaining ring from the vial. Roll the HepaSphere Microspheres vial several times to disperse microspheres. Using a 30mL syringe and a 20G needle, reconstitute the doxorubicin vial with preservative-free 0.9% sodium chloride. DO NOT USE STERILE WATER. Wait 10 min. Using a new 30mL syringe with a new 20G needle, withdraw (the entire contents) from the doxorubicin vial () prepared in Step 3. Using a new 20G needle, inject of doxorubicin from Step 4 into the HepaSphere Microspheres vial. Note: there may be a vacuum in the HepaSphere Microspheres vial. Rotate and invert the HepaSphere Microspheres vial back and forth 5 to 10 times so that the liquid contacts the gray stopper. Let the vial stand for 10 minutes. - Invert and shake every few minutes to continue to mix the spheres with the doxorubicin. Wait 60 min. After the 10 minutes from Step 6, using a new 20G needle, withdraw the entire contents of the HepaSphere Microspheres vial into the 30mL syringe containing the remaining doxorubicin (/) prepared in Step 4. This results in a total of of doxorubicin in of fluid. (Do not attempt to extract every sphere). Gently agitate the syringe to completely mix and disperse the contents. Remove the needle and cap the syringe. Note the time and wait 60 minutes to optimize the uptake of the doxorubicin into the spheres. Agitate every few minutes during loading.

in 1 vial Supplies 2 x doxorubicin powder vial 1 HepaSphere Microspheres vial 6 x 20G needles or larger (18G preferred) 3 x 30mL syringes or larger 4 x vials preservative-free 0.9% sodium chloride for injection - DO NOT USE STERILE WATER 1 syringe cap 1 x syringes Prepare in Biohazard Hood 1 Lift the cap from the HepaSphere Microspheres vial to the vertical position taking care NOT to remove the cap or the metal retaining ring from the vials. 2 Roll the HepaSphere Microspheres vial several times to disperse microspheres. 3 4 5 D1 Wait 10 min. Using a 30mL syringe and a 20G needle, reconstitute one doxorubicin vial with preservative-free 0.9% sodium chloride. DO NOT USE STERILE WATER Using a new syringe with a new 20G needle, withdraw of doxorubicin (D1) into the syringe. Using a new 20G needle on the syringe, inject the entire contents () into the HepaSphere Microspheres vial. This results in of doxorubicin added to the vial. Note: there may be a vacuum in the HepaSphere Microspheres vial. Rotate and invert the HepaSphere Microspheres vial back and forth 5-10 times so that the liquid contacts the gray stopper. Invert and shake every few minutes to continue to mix spheres with doxorubicin. Let the vial stand 10 minutes. 6 7 8 30mL D2 Wait 60 min. Using a new 30mL syringe and a new 20G needle, reconstitute a second doxorubicin vial with preservative-free 0.9% sodium chloride. DO NOT USE STERILE WATER Using a new 30mL syringe with a new 20G needle, withdraw the entire contents of second doxorubicin vial () (D2). After the 10 minutes from Step 5, using a new 20G needle, withdraw the entire contents of the HepaSphere Microspheres vial () into the syringe from Step 7. This results in a total of of doxorubicin in 30mL of fluid. (Do not attempt to remove every sphere.) Gently agitate the syringe to completely mix and dispense the contents. Remove the needle and cap the syringe. Note the time and wait 60 minutes to optimize the uptake of the doxorubicin into the spheres. Agitate every few minutes during loading.

Prepare in Biohazard Hood Steps 1 & 2 1 2 Lift the cap from two HepaSphere Microspheres vials to the vertical position taking care NOT to remove the cap or the metal retaining ring from the vials. Roll the HepaSphere Microspheres vials several times to disperse microspheres. Step 3 3b 3c Wait 10 min. 3a D1 Using a 30mL syringe and a 20G needle, reconstitute one doxorubicin vial with preservative-free 0.9% sodium chloride. DO NOT USE STERILE WATER Using two new syringes and new 20G needles, withdraw of doxorubicin (from D1) into each of the two syringes. VIAL 1 VIAL 2 Using a new 20G needle on each syringe inject the entire contents of one syringe () into each of the HepaSphere Microspheres vials. This results in of doxorubicin in each of the 2 HepaSphere Microspheres vials. Note: There may be a vacuum in the HepaSphere Microspheres vial. Rotate and invert the HepaSphere Microspheres vials back and forth so that the liquid contacts the gray stopper. Invert and shake every few minutes to continue to mix spheres with doxorubicin.

1 in two vials Supplies 3 x doxorubicin powder vials 2 x HepaSphere Microspheres vials 11 x 20G needles or larger (18G preferred) 2 x syringes or larger 5 x 30mL syringes or larger 6 x vials preservative-free 0.9% sodium chloride for injection - DO NOT USE STERILE WATER 2 x syringe caps Step 4 4a 4a Step 5 D2 D3 Using new 30mL syringes and new 20G needles, reconstitute 2 additional vials of of doxorubicin with preservative-free 0.9% sodium chloride in each vial. DO NOT USE STERILE WATER 4b D2 + VIAL 1 4b 30mL Wait 60 min. D3 + VIAL 2 Using two new 30mL syringes and new 20G needles, withdraw the entire contents from each doxorubicin vial into one of the syringes. This results in 2 syringes containing doxorubicin in of fluid in each. 30mL Remove the needles and cap the syringes. Note the time and wait 60 minutes to optimize the uptake of the doxorubicin into the spheres. Agitate every few minutes during loading. After the 10 minutes from Step 3c, using new 20G needles on each of these two 30mL syringes, withdraw the entire contents of one of the HepaSphere Microspheres vials prepared in step 3 (vial1 and vial2) into each syringe from Step 4 (D2 and D3). This results in two 30mL syringes, each containing the contents of one HepaSphere Microspheres vial with of doxorubicin in 30mL of fluid.

www.merit.com Merit Medical Systems, Inc. 1600 West Merit Parkway South Jordan, UT 84095 Tel: 1-801-253-1600 Fax: 1-801-253-1652 Customer Service: 1-800-35-MERiT Merit Medical Systems, Inc. EUROPE, MIDDLE EAST AND AFRICA (EMEA) amerikalaan 42, 6199 ae Maastricht-airport The netherlands Tel: +31 43 358 82 40 BioSphere Medical, S.A. Parc des nations - Paris nord 2 383 Rue de la Belle Etoile 95700 Roissy en France France 2012 Merit Medical Systems, Inc. All rights reserved. MR11-106 Rev B 402279001/B ID 080112